Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00294450 · ClinicalTrials.gov registry record · Phase 2
Feasibility Study of a New Fistula Pouching System
A Phase 2 study of Cutaneous Fistula, sponsored by Coloplast A/S.
- Completed
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
- 7
- Study locations
NCT00294450: Completed Phase 2 study of Cutaneous Fistula, sponsored by Coloplast A/S.
NCT00294450 is a Phase 2 study of Cutaneous Fistula that has completed, run by Coloplast A/S. The registered enrollment target is 22 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (83% lower). The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00294450, a Phase 2 study of Cutaneous Fistula, has completed, sponsored by Coloplast A/S.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this investigation is to carry out a clinical evaluation of a newly developed fistula pouching system's ability to function as a good pouch for fistulas, with the opening on the skin of the stomach or in a wound on the skin of the stomach.
Conditions Studied
Interventions
- DEVICE Fistula Pouching System
Study Locations (7)
Minnesota
- Fairview Southdale Hospital - Edina
- University of Minnesota Medical Center Fairview - Riverside - Minneapolis
- University of Minnesota Medical Center Fairview - Minneapolis
Connecticut
- St. Francis Hospital and Medical Center - Hartford
Florida
- Morton Plant Hospital - Clearwarter
Ohio
- The Cleveland Clinic Foundation - Cleveland
Texas
- Presbyterian Hospital of Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
What the finished NCT00294450 record still lists
NCT00294450 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Cutaneous Fistula appearing as the primary indexed condition, and to 1 intervention - of which Fistula Pouching System is the first listed.
NCT00294450 lists 7 locations in 5 states (Minnesota, Connecticut, Florida).
Frequently Asked Questions
What is clinical trial NCT00294450 about?
NCT00294450 is a clinical study titled "Feasibility Study of a New Fistula Pouching System". The purpose of this investigation is to carry out a clinical evaluation of a newly developed fistula pouching system's ability to function as a good pouch for fistulas, with the opening on the skin of the stomach or in a wound on the skin of the stomach.
What is the current status of trial NCT00294450?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2006-02. Estimated completion is 2007-03.
What conditions does trial NCT00294450 study?
This clinical trial studies the following conditions: Cutaneous Fistula.
What interventions are being tested in trial NCT00294450?
The interventions under investigation include: Fistula Pouching System (DEVICE).
Who is sponsoring clinical trial NCT00294450?
This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00294450 being conducted?
This trial has 7 study locations across Connecticut, Florida, Minnesota, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00294450's enrollment target sits among peer trials
22 1790th of 2000 higher than 207 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia